Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: A pilot study

Pediatric Pulmonology

Volumn 32, Issue 4, 2001, Pages 293-302

  Wojtczak, Henry A ^a   Kerby, Gwendolyn S ^b   Wagener, Jeffrey S ^c   Copenhaver, Steven C ^d   Gotlin, Ronald W ^e   Riches, David W H ^c   Accurso, Frank J ^a,b,c,e  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d Mike McMorris Cystic Fibrosis Care and Research Center   (United States)

^e SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Airway inflammation; Bronchoalveolar lavage; Children; Cystic fibrosis; Inhaled corticosteroids; Macrophage; Neutrophil

Indexed keywords

ALPHA 1 ANTITRYPSIN; BECLOMETASONE DIPROPIONATE; CA 19-9 ANTIGEN; CORTICOTROPIN; EOSINOPHIL CATIONIC PROTEIN; HEMOGLOBIN A1C; HYDROCORTISONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADOLESCENT; ADRENAL SUPPRESSION; ARTICLE; BACTERIUM CULTURE; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG SAFETY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LUNG LAVAGE; MACROPHAGE; MALE; NEUTROPHIL; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL GLANDS; AIRWAY RESISTANCE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; MALE; NEBULIZERS AND VAPORIZERS; PILOT PROJECTS; PROBABILITY; PROSPECTIVE STUDIES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0034790494     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1122     Document Type: Article

References (40)

1. Cystic fibrosis
2. Bronchoalveolar lavage findings in cystic fibrosis patients with stable clinically mild lung disease suggests ongoing infection and inflammation
3. Early pulmonary inflammation in infants with cystic fibrosis
4. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
5. The relationship between infection and inflammation in early stages of lung disease from cystic fibrosis
6. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis
7. A multicenter study of alternate-day prednisone in patients with cystic fibrosis
8. Risks of alternate day prednisone in patients with cystic fibrosis
9. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: Influence of local steroid treatment
10. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis
11. Randomised controlled trial of inhaled corticosteroids (fluticasone proprionate) in cystic fibrosis
12. The effects of inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis
13. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection
14. The use of anti-inflammatory medications in cystic fibrosis: Trends and physician attitudes
15. International practice patterns by age and severity of lung disease in cystic fibrosis: Data from the Epidemiologic Registry of Cystic Fibrosis (ERCF)
16. Fluticasone proprionate 750 μg/day versus beclomethasone diproprionate 1500 μg/day: Comparison of efficacy and adrenal function in paediatric asthma
17. Is the acquisition of Pseudomonas in cystic fibrosis patients increased by use of inhaled corticosteroids? Unexpected results from a double-blind, placebo-controlled study
18. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis
19. Inflammatory cytokines in cystic fibrosis lungs
20. Outcome measures for clinical trials in cystic fibrosis: Summary of a Cystic Fibrosis Foundation consensus conference
21. Inhaled glucocorticoid therapy in children: How much is safe?
22. Use of topical corticosteroids in the treatment of childhood asthma
23. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children
24. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma
25. Twice-daily beclomethasone dipropionate in the treatment of childhood asthma
26. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze France, October 1992
27. Endocrine and lung function in asthmatic children on inhaled corticosteroids
28. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids
29. Normative data for adrenal steroidogenesis in a healthy pediatric population: Age- and sex-related changes after adrenocorticotropin stimulation
30. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of inflammation
31. Relationship between disease severity and inflammatory markers in cystic fibrosis
32. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo
33. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis
34. Monocyte adherence results in selective induction of novel genes sharing homology with mediators of inflammation and repair
35. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma
36. Infection and inflammation of the lung in cystic fibrosis
37. Inflammation in the cystic fibrosis lung - A vicious cycle that does more harm than good?
38. Human neutrophil elastase and elastase/alphalantiprotease complex in cystic fibrosis
39. Changes in CA 19-9 antigen and Lewis blood group with pulmonary disease severity in cystic fibrosis
40. Effects of glucocorticoids on inflammatory cells relevant to their application in asthma